Log in
Enquire now
Lungpacer Medical Inc.

Lungpacer Medical Inc.

Lungpacer Medical Inc. is developing diaphragm pacing therapy for preserving or restoring the integrity and strength of the diaphragm muscle.

OverviewStructured DataIssuesContributors

Contents

TimelineTable: Funding RoundsTable: ProductsTable: AcquisitionsTable: SBIR/STTR AwardsTable: PatentsTable: Further ResourcesReferences
lungpacer.com
Is a
Organization
Organization
Company
Company

Company attributes

Industry
Internal medicine
Internal medicine
Engineering
Engineering
Biomedical engineering
Biomedical engineering
Healthcare
Healthcare
Loading...
Respiratory care
Respiratory care
Medicine
Medicine
Location
Vancouver
Vancouver
Exton, Pennsylvania
Exton, Pennsylvania
Pitchbook URL
pitchbook.com/profiles...108232-84
Email Address
info@lungpacer.com
Full Address
Suite 130, 601 W Cordova Street Vancouver, B.C. V6B 1G1 Canada
Investors
Keiretsu Capital
Keiretsu Capital
NEA (New Enterprise Associates)
NEA (New Enterprise Associates)
Keiretsu Forum
Keiretsu Forum
Founded Date
2009
Total Funding Amount (USD)
91,400,000
Latest Funding Round Date
January 2021
Latest Funding Type
Private equity
Private equity
Patents Assigned (Count)
4
Country
Canada
Canada
Headquarters
Vancouver
Vancouver

Other attributes

Company Operating Status
Active
Latest Funding Round Amount (USD)
16,000,000

Lungpacer Medical Inc. is a medical device company located in Vancouver, British Columbia. The company is developing and commercializing a novel therapeutic solution that addresses the significant health and cost issues associated with mechanical ventilation of critically ill patients in hospital Intensive Care Units (ICU).

The therapeutic technology aims to preserve the integrity and strength of the diaphragm muscle in critically ill patients. The proprietary Lungpacer system is designed to activate the diaphragm using a temporary, minimally invasive, transvascular nerve stimulation approach to save lives, improve surviving patient outcomes and greatly reduce hospital care costs.

As of March 2020, the Lungpacer Diaphragm Pacing Therapy System is limited by Federal (United States) law to investigational use. The device is not approved for sale in the United States or Europe.

Timeline

No Timeline data yet.

Funding Rounds

Products

Acquisitions

SBIR/STTR Awards

Patents

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more companies like Lungpacer Medical Inc.

Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.